Protagonist Therapeutics, Inc. (PTGX): Margin dodolan operasi

Logo grafis Protagonist (PTGX)

The operating profit margin visualizes profitability dynamics, where 58.60 expresses the latest level of the metric. Protagonist Therapeutics (PTGX) optimizes tests through external contractors while retaining intellectual property rights. The business relies on a portfolio of peptide developments in immunology to minimize risks. High scalability allows the company to generate colossal revenue with minimal production costs following drug patenting.

PTGX: Margin operasi protagonist-inc.com 04.07.2022 - 19.11.2026

Rincian metrik lan analitis perusahaan protagonist-inc.com (PTGX)

Analisis umum perusahaan:Protagonist Corp, PTGX
Barang utama Protagonist Therapeutics

Investors are assessing the resilience of Protagonist Therapeutics (PTGX) through its operating margin, calculated as the ratio of operating profit before interest and taxes to total revenue. An analysis of the operating margin chart reveals how effectively the company monetizes its peptide developments, given that biotech binary risks are mitigated here by subsidies from strategic pharmaceutical partners.

Analisis pesaing

ARGX (argenx N.V.) - Margin operasi|Rentabilitas dodolan operasi BioNTech Pharma BNTX|Margin dodolan operasi ABVX (ABIVAX)|Margin operasi ADMA Biologics, Inc. (ADMA)|Rentabilitas operasi Immunovant Corp IMVT|Margin operasi Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Rentabilitas operasi|Rentabilitas kegiatan operasi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Margin dodolan operasi|Aurinia Pharmaceuticals Inc. (AUPH) - Margin operasi|Margin dodolan operasi BCRX|Rentabilitas dodolan operasi Vera Therapeutics Inc VERA|Margin dodolan operasi DNTH (Dianthus Pharma)|Rentabilitas kegiatan operasi Pharvaris N.V.|AbCellera Biologics Inc - Margin dodolan operasi|Tourmaline Bio (TRML) - Rentabilitas dodolan operasi|PGEN - Rentabilitas operasi|Tingkat bathi operasi PHAR (Pharming Group NV)|NKTR: Margin operasi|Upstream Bio Corp - Tingkat bathi operasi|Rentabilitas operasi Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Rentabilitas kegiatan operasi|Margin operasi GOSS|Margin dodolan operasi KalVista Pharmaceuticals, Inc. KALV|Rentabilitas operasi Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Rentabilitas dodolan operasi|SVRA - Rentabilitas operasi|Rigel Pharmaceuticals - Rasio bathi operasi|AnaptysBio Corp (ANAB) - Rentabilitas operasi|ATXS - Rentabilitas kegiatan operasi|Rentabilitas operasi enGene Holdings Inc.|RAPT: Tingkat bathi operasi|Margin operasi JBIO|Margin dodolan operasi aclaristx.com ACRS|Rentabilitas operasi Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Rentabilitas dodolan operasi|Cabaletta Bio, Inc - Margin operasi|Rentabilitas dodolan operasi Ventyx Biosciences|THTX (theratech.com) - Margin dodolan operasi|Margin dodolan operasi Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Margin operasi|Rentabilitas dodolan operasi Agenus Inc. AGEN|Margin dodolan operasi CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Tingkat bathi operasi|Rentabilitas operasi atyrpharma.com ATYR|Margin operasi Adagene Corp ADAG|IMA - Rentabilitas operasi|Tingkat bathi operasi STTK (Shattuck Labs)|EQ: Margin operasi|Connect Biopharma (CNTB) - Margin operasi|Rentabilitas operasi Immunic|Margin operasi atarabio.com|Margin operasi IFRX|Margin operasi X4 Pharma (XFOR)|Margin operasi ACET (adicetbio.com)|Margin operasi Celularity Inc. CELU|INMB - Rentabilitas operasi|Tingkat bathi operasi BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Margin dodolan operasi|Margin dodolan operasi SAB Biotherapeutics Inc.|Margin dodolan operasi AKTX|Margin dodolan operasi enlivex.com (ENLV)|Rentabilitas operasi Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Tingkat bathi adhedhasar bathi operasi|Margin operasi EDSA (Edesa Biotech Corp)|Rentabilitas kegiatan operasi iBio (IBIO)|CARM - Rentabilitas operasi|XTL Biopharmaceuticals (XTLB) - Margin dodolan operasi|BOLT: Margin operasi|Margin dodolan operasi HCW Biologics Inc.|Rentabilitas operasi Aptevo|Rentabilitas dodolan miturut bathi operasi AIM (AIM ImmunoTech, Inc.)|Margin operasi ADTX|Rentabilitas kegiatan operasi GRI Bio Corp|Margin operasi XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Rentabilitas dodolan operasi|Revelation Biosciences Corp - Margin operasi|INDP (Indaptus Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi operasi|SCNI: Margin operasi|CALI - Rentabilitas kegiatan operasi|AFMD (Affimed N.V.) - Margin operasi|Rentabilitas operasi ALLK|Margin dodolan operasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Rentabilitas dodolan operasi|Rentabilitas operasi iTeos ITOS|Ocean Bio - Rentabilitas operasi|TC BioPharm Ltd - Margin operasi|Rentabilitas dodolan operasi thirdharmonicbio.com